Nirogacestat and its Impurities

Nirogacestat is an oral gamma-secretase inhibitor used for the treatment of adults with progressing desmoid tumors, working by blocking Notch signaling to reduce tumor growth and improve disease control Reference standards of Nirogacestat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 9 results for Nirogacestat Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 14 1630000

Nirogacestat

Nirogacestat


  • Catalogue No.:PA 14 1630000

  • CAS :

    1290543-63-3

  • Molecular Formula : C27H41F2N5O

  • Molecular Weight : 489.66

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631000

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentyl(nitroso)amino)propan-2-yl)-1H-imidazol-4-yl)pentanamide

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentyl(nitroso)amino)propan-2-yl)-1H-imidazol-4-yl)pentanamide


  • Catalogue No.:PA 14 1631000

  • CAS :

    NA

  • Molecular Formula : C27H40F2N6O2

  • Molecular Weight : 518.65

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631001

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide


  • Catalogue No.:PA 14 1631001

  • CAS :

    NA

  • Molecular Formula : C27H40F2N6O2

  • Molecular Weight : 518.65

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631002

N-(2-Methyl-2-(4-nitro-1H-imidazol-1-yl)propyl)-N-neopentylnitrous amide

N-(2-Methyl-2-(4-nitro-1H-imidazol-1-yl)propyl)-N-neopentylnitrous amide


  • Catalogue No.:PA 14 1631002

  • CAS :

    NA

  • Molecular Formula : C12H21N5O3

  • Molecular Weight : 283.33

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631003

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)pentanoic Acid

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)pentanoic Acid


  • Catalogue No.:PA 14 1631003

  • CAS :

    NA

  • Molecular Formula : C15H18F2N2O3

  • Molecular Weight : 312.32

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631004

N-(2-(4-Amino-1H-imidazol-1-yl)-2-methylpropyl)-N-neopentylnitrous amide

N-(2-(4-Amino-1H-imidazol-1-yl)-2-methylpropyl)-N-neopentylnitrous amide


  • Catalogue No.:PA 14 1631004

  • CAS :

    NA

  • Molecular Formula : C12H23N5O

  • Molecular Weight : 253.35

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631005

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)-N-(1-(2-methyl-1-(neopentyl(nitroso)amino)propan-2-yl)-1H-imidazol-4-yl)pentanamide

(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)-N-(1-(2-methyl-1-(neopentyl(nitroso)amino)propan-2-yl)-1H-imidazol-4-yl)pentanamide


  • Catalogue No.:PA 14 1631005

  • CAS :

    NA

  • Molecular Formula : C27H39F2N7O3

  • Molecular Weight : 547.65

Drug Reference Standards & Impurity Synthesis in India
PA 14 1631006

Methyl (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)pentanoate

Methyl (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)(nitroso)amino)pentanoate


  • Catalogue No.:PA 14 1631006

  • CAS :

    NA

  • Molecular Formula : C16H20F2N2O3

  • Molecular Weight : 326.34

Drug Reference Standards & Impurity Synthesis in India
PA STI 090181

Nirogacestat-D5

Nirogacestat-D5


  • Catalogue No.:PA STI 090181

  • CAS :

    NA

  • Molecular Formula : C27H36D5F2N5O

  • Molecular Weight : 494.69